June 3, 2018

FIRST, DO NO HARM:

For Some Breast Cancer Patients, The Chemo Decision Just Got Easier (SARA KILEY WATSON, 6/03/18, NPR)

A study published Sunday finds that many women with early-stage invasive breast cancer could safely forgo chemotherapy, if they score in the midrange or lower for risk that their cancer will recur, as measured by a commonly used genomic test

The study, published Sunday in the New England Journal of Medicine, finds that patients who fall in the intermediate risk zone do as well with hormone therapy alone as with chemo plus hormone therapy after surgery. "[The findings] are both important and significant, and also practice-changing," says, Dr. José Baselga, a medical oncologist and physician in chief at Memorial Sloan Kettering Cancer Center in New York, who was not involved with this research. "Basically, it's going to spare a lot of unnecessary chemotherapy in patients with breast cancer."

Posted by at June 3, 2018 7:58 AM

  

« TREAT HIM LIKE HIS PAL VLAD: | Main | EAU DU DONALD: »